Stockreport

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

MaxCyte, Inc.  (MXCT) 
PDF ROCKVILLE, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform tec [Read more]